Work

Concordance between bone marrow and blood measurable residual disease after first-line novel agent treatment for chronic lymphocytic leukemia: a systematic review and meta-analysis

Year: 2026

Type: review

Source: Leukemia

DOI: 10.1038/s41375-026-03178-9

Authors: Giuseppe Fiorica, Graham Wehmeyer, Claire I. Yee, Diana Segovia, Fausto Alfredo Rios-Olais, Talal Hilal, Adam S. Kittai

Institutions: Icahn School of Medicine at Mount Sinai, Tisch Cancer Institute, Mayo Clinic in Arizona, Instituto Nacional de Ciencias Médicas y Nutrición Salvador Zubirán, Mayo Clinic Hospital, NYU Langone’s Laura and Isaac Perlmutter Cancer Center, NYU Grossman Long Island School of Medicine

Language: English

Topic: Chronic Lymphocytic Leukemia Research

Subfield: Hematology

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W7223177333

FWCI:

Cites: 8

Cited by:

Related to: 10